Risk of recurrent venous thromboembolism and major hemorrhage in cancer‐associated incidental pulmonary embolism among treated and untreated patients: a pooled analysis of 926 patients

Essentials•We performed a pooled analysis of 926 patients with cancer‐associated incidental pulmonary embolism (IPE).•Vitamin K antagonists (VKA) are associated with a higher risk of major hemorrhage.•Recurrence risk is comparable after subsegmental and more proximally localized IPE.•Our results support low molecular weight heparins over VKA and similar management of subsegmental IPE.Summary: BackgroundIncidental pulmonary embolism (IPE) is...